Opinions Ionis and Royalty Pharma input into royalty settlement for as much as $1.1 billion to additional advance Ionis’ genetic medications and industrial readinessBy saqibshoukat1989January 9, 20230 Royalty Pharma to procure an pastime in SPINRAZA® and pelacarsen royalties — Ionis keeps majority of royalties and all milestones…
